Abstract
Effects were studied of wobenzyme on atherogenicity of blood serum and immunoinflammatory reactions in patients with myocardial infarction during the rehabilitation stage over six months. The basis therapy when supplemented with wobenzyme was found out to facilitate normalization of the atherogenic potential and to have a positive action on the mediators of the inflammatory process.
Publication types
-
Clinical Trial
-
Comparative Study
-
English Abstract
MeSH terms
-
Adjuvants, Immunologic / therapeutic use*
-
Adult
-
Arteriosclerosis / blood
-
Arteriosclerosis / immunology
-
Arteriosclerosis / prevention & control*
-
Drug Combinations
-
Drug Therapy, Combination
-
Humans
-
Hydrolases / therapeutic use*
-
Inflammation Mediators / blood
-
Male
-
Middle Aged
-
Myocardial Infarction / blood
-
Myocardial Infarction / immunology
-
Myocardial Infarction / rehabilitation*
-
Rutin / therapeutic use*
-
Time Factors
Substances
-
Adjuvants, Immunologic
-
Drug Combinations
-
Inflammation Mediators
-
Rutin
-
Wobenzym
-
Hydrolases